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Abstract: Introduction: Scardovia wiggsiae (SW) is a newly identified cariogenic pathogen associated
with severe early childhood caries and oral disease. New studies have confirmed the presence of
this organism among clinical samples from both pediatric and adult patients. However, the recent
discovery of this organism has left researchers with only limited information available regarding
the prevalence of this organism—and virtually no information regarding oral site-specific locations.
Based upon this lack of information, the overall objective of this study was to perform an oral
site-specific analysis of SW prevalence from clinical samples. Methods: Using an approved human
subjects protocol, samples (n = 60) from an existing saliva and site-specific biorepository were
identified and screened for SW presence using quantitative polymerase chain reaction (qPCR). These
data were summarized and subsequently analyzed for correlations with demographic (age, sex, race
or ethnicity) or clinical (body mass index or BMI, primary/mixed/permanent dentition, orthodontic
brackets) variables. Results: These data revealed that average DNA concentrations from all sample
sites (saliva, dorsum of tongue, gingival crevicular fluid (GCF), biofilm of upper buccal molar, and
biofilm of lower lingual incisor) ranged between 13.74 and 14.69 µg/µL, with an overall average of
14.30 µg/µL ± 1.12 (standard error or SE). qPCR screening revealed a total of n = 34/60 or 56.7%
of patient samples harboring SW. A total of n = 71/170 specific oral sites harbored this organism,
with the majority of the SW-positive participant samples harboring SW at more than one oral site,
n = 22/34 or 64.7%, including non-traditional sites such as GCF and the dorsum of the tongue. Weak
correlations were found between specific SW outcomes in GCF and type of dentition (permanent;
R = 0.2444), as well as SW outcomes in saliva with age (R = 0.228) and presence of orthodontic
brackets (R = 0.2118). Conclusions: This study may be among the first to provide oral site-specific
analysis to reveal the prevalence and location of Scardovia among clinical patient samples. Moreover,
these data also provide some of the first evidence to suggest this organism may be present not
only in traditional supragingival tooth-associated biofilm sites, but also in non-traditional oral sites
including the dorsum of the tongue and the gingival crevice. Based upon these results, these data
may represent a significant advance in our understanding of the potential sites and locations that
harbor this organism and may help contribute to our understanding of the prevalence, distribution
and potential for the development of oral disease among clinic patients.
Keywords: Scardovia wiggsiae; dental caries; saliva screening
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1. Introduction
Scardovia wiggsiae (SW) is a recently identified, Gram-positive cariogenic pathogen
strongly associated with poor health outcomes and oral disease [1,2]. More specifically, SW
has subsequently been characterized as an anaerobic, Gram-positive bacillus most closely
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related to Scardovia inopinata [3]. Genetic analysis revealed this organism as saccharolytic,
with the potential capability for both acetic and lactic acid fermentation pathways [4].
These potential capabilities suggested this organism might therefore be a contributor to the
oral biofilm responsible for the development or progression of oral caries [5].
Many studies now confirm the presence and rising levels of this pathogen in cases of
severe and early childhood caries [6–8]. This organism may represent a unique niche in
the oral biofilm, with the ability to metabolize glucose and produce fermentation products
lactic, acetic and formics acid with higher fluoride tolerance and lower enolase sensitivity
than other cariogenic pathogens, such as Streptococcus mutans (SM) [9,10].
The ability for SW and other Bifidobacteria to metabolize glucose apart from the fluorideinhibited enolase and lactic acid-producing pathway through a shunt allowing metabolic
activity and the production of acetate to continue has been identified as an important
virulence mechanism [10–12]. Because the incorporation of fluoride into toothpastes,
mouthwashes and topical applications is an important feature of anti-cariogenic oral
health strategies, understanding the prevalence of SW and other organisms that may be
resistant to fluoride at SM-inhibitory concentrations as well as understanding the oral
sites and locations for the aggregation of this organism and methods for altering biofilm
composition become increasingly important [13–15]. Pilot studies from this group have
explored alternative methods for decreasing the cariogenic bacterial burden among children
by evaluating the effect of dental sealants, which may exhibit modest and temporary effects
on SW—although much remains to be discovered regarding the oral sites and prevalence
of this organism [16,17].
Based upon the limited applicability of most cariogenic-inhibiting treatments and therapies to target SW specifically, an understanding of the overall prevalence of this organism
has been increasingly important [18,19]. Studies from this group have also evaluated the
prevalence and distribution of this organism among pediatric and adult clinical patient
samples [20,21]. These studies have confirmed previous work suggesting that orthodontic
therapy may be a potential risk factor influencing the growth and development of this
organism [22,23]. These have led to additional research from this group to evaluate the
populations, including pediatric and adult orthodontic patients, most at risk for harboring
this organism [24–26].
Most recently, a series of site-specific sampling studies from this group have revealed
differential oral locations for SW distribution among patient samples—a major step towards understanding the potential sites for colonization [27,28]. However, due to the
limited number of patient samples available in these initial studies, a larger and more
comprehensive microbial screening analysis was the overall objective of this current study.
By combining a larger study sample and site-specific data with demographic, clinical and
orthodontic treatment variables, it is hoped a more complete and thorough understanding
of oral location, risk factors and prevalence can be accomplished.
2. Materials and Methods
2.1. Study Approval
The protocol for this retrospective study was reviewed and approved by the Biomedical institutional review board (IRB) and Office for the Protection of Research Subjects
(OPRS) at the University of Nevada, Las Vegas (UNLV) under 1717625-1 titled “Retrospective analysis of microbial prevalence from DNA isolated from saliva samples originally
obtained from the University of Nevada, Las Vegas (UNLV) School of Dental Medicine
(SDM) pediatric and clinical population”. The original study sample collection was reviewed and approved by the UNLV IRB under OPRS#1305-4466M “The Prevalence of Oral
Microbes in Saliva from the UNLV School of Dental Medicine Pediatric and Adult Clinical
Population” in 2013.
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2.2. Sample Collection
The original sample collection was performed in the UNLV SDM clinics. Participation
was voluntary and all study participants were required to provide informed consent if
over the age of 18 years old or pediatric assent if under the age of 18 years old. Exclusion
criteria included any patients (or parents/guardians) that declined to participate and
any persons not a patient of record at UNLV-SDM. Inclusion criteria were indication of
voluntary participation and provision of informed consent and/or pediatric assent.
In brief, study sample participants were provided sterile saliva collection tubes, which
were labeled with randomly generated, non-duplicated numbers to prevent any association with patient identifying information. In addition, paper points were used to collect
biofilm samples from the dorsum of the tongue, lingual surface of a mandibular incisor,
buccal surface of a maxillary molar, and the gingival crevice of the central maxillary incisor. Basic demographic information for each sample was collected, which included
age, sex, race/ethnicity and body mass index (BMI). Clinical information, such as primary/mixed/permanent dentition and the presence of orthodontic brackets, was also
collected. All samples were then transferred to a biomedical laboratory for storage at
−80 ◦ C, processing and subsequent analysis.
2.3. DNA Isolation and Analysis
DNA was isolated from 100 µL of saliva samples and from paper points that were
placed into 100 µL of sterile 1X phosphate-buffered saline (PBS) and vortexed to release any
bacteria or other microbial constituents. Each sample was then processed using the phenol:
chloroform extraction method, as previously described [21,28]. In brief, 300 µL of TriZol
was added to each sample and mixed to dissolve microbial membranes and cell walls. A
volume of 200 µL of chloroform was added and mixed prior to centrifugation at 12,000× g
or relative centrifugal force (RCF) for 15 min to separate the proteins and nucleic acids.
The aqueous supernatant containing the nucleic acids was removed and transferred to
new sterile microcentrifuge tubes and mixed with 100 µL of isopropanol to precipitate the
DNA, which was then centrifuged. The pellet was washed with nuclease-free ethanol prior
to subsequent centrifugation and resuspension in 100 µL of sterile, nuclease-free water.
Each sample was then screened for DNA concentration and purity using a NanoDrop
spectrophotometer using absorbance readings at A260 and A280 nm.
2.4. qPCR Screening
Samples with sufficient quantity (>10 ng) and quality A260:A280 ratio above 1.70
were then screened for microbial presence using quantitative polymerase chain reaction
(qPCR) primers specific for the bacterial positive control (16S rRNA universal primer) and
Scardovia wiggsiae (SW). In brief, each qPCR screening was performed in duplicate and
consisted of a reaction containing 2X ABsolute SYBR green master mix (12.5 µL), forward
and reverse primers (1.5 µL each), sample DNA (1.5 µL diluted to 1.0 ng/µL) and distilled
nuclease-free water (8.0 µL). Processing was performed using activation at 95 ◦ C for 15 min,
followed by 40 cycles involving denaturation (95 ◦ C for 15 s), annealing (primer-specific
temperatures below for 30 s) and extension (72 ◦ C for 30 s).
Positive control, bacterial 16S rRNA
Forward 16S rRNA universal primer
50 -ACG CGT CGA CAG AGT TTG ATC CTG GCT-30 ; Tm = 76 ◦ C
Reverse 16S rRNA universal primer
50 -GGG ACT ACC AGG GTA TCT AAT-30 ; Tm = 62 ◦ C
Annealing temperature = lower Tm (62 ◦ C) − 2 ◦ C = 60 ◦ C.
2.5. Scardovia Wiggsiae (SW)
SW Forward primer
50 -GTG GAC TTT ATG AAT AAG C-30 ; Tm = 55 ◦ C
SW Reverse primer
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50 -CTA CCG TTA AGC AGT AAG-30 ; Tm = 56 ◦ C
Annealing temperature = lower Tm (55 ◦ C) − 2 ◦ C= 53 ◦ C.
2.6. Statistical Analysis
Demographic variables were summarized and descriptive statistics reported. Any
differences between the study sample demographics and the overall clinic population were
analyzed using chi square statistics, which is appropriate for categorical, non-parametric
data. Parametric data (such as DNA concentration) were summarized and descriptive
statistics reported. Any differences between samples were analyzed using two-tailed
Students’ t-tests, which are appropriate for continuous parametric data analysis. Any
associations between demographic or clinical characteristics and the screening outcomes
were analyzed using binomial logistic regression analysis.
3. Results
A total of n = 60 patient samples were identified for inclusion in this study (Table 1).
Demographic analysis of the study sample participants revealed that slightly more than
one-third were derived from females (n = 22/60 or 36.7%), which was significantly different
from the overall percentage of females from the clinic population (49.1%), p = 0.0164. The
percentage of minorities was also much higher within the study sample (n = 52/60 or 86.7%)
than in the clinic population (65.4%), which was also statistically significant, p = 0.00012.
Finally, the average age of the study sample was 11.01 years, which was not significantly
different from the pediatric clinic patient population of 10.41 years, p = 0.441.
Table 1. Demographic analysis of study sample.
Study Sample

Clinic Population

Statistical Analysis

n = 22/60 (36.7%)
n = 38/60 (63.3%)

49.1%
50.9%

X2 = 5.762, d.f. = 1
p = 0.0164

n = 8/60 (13.3%)
n = 52/60 (86.7%)
n = 40/60 (66.7%)
n = 8/60 (13.3%)
n = 40/60 (6.7%)

34.6%
65.4%
58.6%
10.2%
6.6%

X2 = 21.275, d.f. = 1
p = 0.00012

11.01 years
5–17 years

10.41 years
0–17 years

p = 0.441

Sex
Females
Males
Race/Ethnicity
White
Minority
Hispanic
Black
Asian
Age
Average age
Range

To determine whether the DNA isolated from these samples had sufficient quality and
quantity for molecular screening using qPCR, analysis was performed using spectrophotometry (Table 2). These data revealed that the average DNA concentration from all sample
sites ranged between 13.74 and 14.69 µg/µL, with an overall average of 14.30 µg/µL ± 1.12
(standard error or SE). None of the site-specific averages were significantly different from
the overall average of all site combined, p = 0.643. DNA purity as measured by the ratio of
absorbance at A260 and A280 nm revealed that average purity for all sites exceeded 1.60
(range 1.618 to 1.701), which has been deemed acceptable for molecular screening using
high-fidelity methods such as qPCR.
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Table 2. Analysis of DNA isolated from study samples.
Table 2. Analysis of DNA isolated from study samples.

DNA Concentration
DNA Concentration
(Average
± Standard
(Average ± Standard
Error
Erroror
orSE)
SE)
Gingival Crevice
14.69 ug/uL ± 1.24 SE
Gingival Crevice
14.69 µg/µL ± 1.24 SE
Upper
Molar
14.34
UpperBuccal
Buccal Molar
14.34ug/uL
µg/µL±±1.17
1.17SE
SE
Lower
Incisor 14.40
LowerLingual
Lingual Incisor
14.40ug/uL
µg/µL±±1.16
1.16SE
SE
DorsalTongue
Tongue
14.34ug/uL
µg/µL±±1.05
1.05SE
SE
Dorsal
14.34
Saliva
13.74ug/uL
µg/µL±±1.01
1.01SE
SE
Saliva
13.74
Average
14.30 µg/µL ± 1.12 SE
Average
14.30 ug/uL ± 1.12 SE

DNA Purity
DNA Purity
A260:A280
A260:A280

1.701 ± 0.21
1.701 ± 0.21
1.691
0.24
1.691±±
0.24
1.672
0.27
1.672±±
0.27
1.637±±
0.31
1.637
0.31
1.618±±
0.28
1.618
0.28
1.664 ± 0.26
1.664 ± 0.26

Statistical Analysis
Statistical Analysis

p = 0.722
p = 0.722
pp==0.887
0.887
pp==0.772
0.772
0.911
pp==0.911
0.643
pp==0.643

Confirmation of
bacterial DNA
presence from
Confirmation
of bacterial
DNA presence
from each
each study
study sample
sample was
was accomplished
accomplished
using real-time
chain
reaction
(RT-qPCR)
usingusing
bacterial
16S rRNA
using
real-timequantitative
quantitativepolymerase
polymerase
chain
reaction
(RT-qPCR)
bacterial
16S
universal
primers
(Figure
1).
These
data
demonstrated
that
all
patient
samples
and
study
rRNA universal primers (Figure 1). These data demonstrated that all patient samples and
sites harbored
detectable
levels oflevels
bacterial
DNA. More
specifically,
the cycle threshold
study
sites harbored
detectable
of bacterial
DNA.
More specifically,
the cycle
counts
(CT)
for
saliva
ranged
between
22
and
30
(average
28.6),
with
more
narrow
threshold counts (CT) for saliva ranged between 22 and 30 (average 28.6),
withranges
more
observedranges
amongobserved
the other among
sites, such
dorsal
tongue
25–30;
average
29.4), 25–30;
upper
narrow
theasother
sites,
such(range:
as dorsal
tongue
(range:
buccal molar
average
lower
lingual
incisor30.1),
(range:
27–31;
average
29.9)
average
29.4),(range:
upper27–30,
buccal
molar30.1),
(range:
27–30,
average
lower
lingual
incisor
and gingival
fluidand
(range:
26–30;
average fluid
30.6). (range: 26–30; average 30.6).
(range:
27–31;crevicular
average 29.9)
gingival
crevicular

Figure 1. qPCR screening of samples for positive control 16S rRNA. All study samples harbored bacterial DNA with average
cycle threshold (CT) counts ranging from 28.6 (saliva and lower lingual incisor), 29.9 (dorsal tongue), to 30.1 (upper buccal
molar and gingival crevicular fluid).

Screening of these samples for SW revealed that more than half of all study sample
participants had at least one site harboring this organism, n = 34/60 or 56.7% (Figure 2).
Analysis of the SW-positive patient samples revealed a total of n = 71/170 specific oral

Figure 1. qPCR screening of samples for positive control 16S rRNA. All study samples harbored bacterial DNA with
average cycle threshold (CT) counts ranging from 28.6 (saliva and lower lingual incisor), 29.9 (dorsal tongue), to 30.1
(upper buccal molar and gingival crevicular fluid).
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Screening of these samples for SW revealed that more than half of all study sample
participants had at least one site harboring this organism, n = 34/60 or 56.7% (Figure 2).
Analysis of the SW-positive patient samples revealed a total of n = 71/170 specific oral sites
that
this this
organism,
with
thethe
majority
ofofthe
sites harbored
that harbored
organism,
with
majority
theSW-positive
SW-positiveparticipant
participant samples
harboring
one oral
oral site,
site, nn == 22/34
22/34 or 64.7% (Figure 2A). More detailed
harboring SW at more than one
revealed that the majority
majority of
of the
the single-site
single-site SW-positive
SW-positive results came
analysis of these sites revealed
from the dorsal tongue
tongue (n
(n == 5/12
5/12 or
buccal molar
molar (n
(n == 3/12
3/12 or 25%) or
or 41.7%), with upper buccal
saliva (n == 3/12
3/12or
or25%)
25%)comprising
comprisingthe
thebulk
bulkof
ofthe
theremaining
remainingsites.
sites.
The majority of SW-positive samples harbored SW at more than one oral site, with
mostcommon
commonsites
sitesrevealed
revealed
lower
lingual
incisor
= 18/59
or 30.5%)
and
the most
asas
thethe
lower
lingual
incisor
(n = (n
18/59
or 30.5%)
and upper
upper molar
buccal(nmolar
(n or
= 16/59
27.1%)
(n 20.3%)
= 12/59
or 20.3%)
(Figure
buccal
= 16/59
27.1%) or
and
salivaand
(n = saliva
12/59 or
(Figure
2B). Fewer
of 2B).
the
Fewer of with
the samples
with
multiple
sites
harbored
SWdorsal
from tongue
the dorsal
(n 11.9%)
= 7/59 or
samples
multiple
sites
harbored
SW
from the
(n tongue
= 7/59 or
11.9%) orcrevicular
gingival crevicular
fluidor(n10.2%).
= 6/59The
or 10.2%).
Thetotal
combined
of both
gingival
fluid (n = 6/59
combined
of bothtotal
singleand singlemultiand
multi-site
data
revealed
that
the
most
common
sites
overall
were
from
the
biofilm
site data revealed that the most common sites overall were from the biofilm samples
samples from
derived
upper
buccal
19/71and
or 26.8%)
and lower
lingual
derived
the from
upperthe
buccal
molar
(n =molar
19/71 (n
or =26.8%)
lower lingual
incisor
(n =
incisoror(n25.4%),
= 18/71
or 25.4%),
many
of these
also demonstrating
SW-positive
18/71
with
many ofwith
these
samples
alsosamples
demonstrating
SW-positive results
from
results
from the corresponding
saliva
= 15/71
or 21.1%).
fewersamples
SW-positive
the
corresponding
saliva (n = 15/71
or (n
21.1%).
Overall,
fewerOverall,
SW-positive
were
samples
were
found
among
the
dorsal
tongue
(n
=
12/71
or
16.9%)
and
gingival
crevicular
found among the dorsal tongue (n = 12/71 or 16.9%) and gingival crevicular fluid (n = 7/71
fluid
(n = 7/71 or 9.9%).
or
9.9%).

A
Saliva
Dorsal Tongue (DT)
Upper Buccal Molar (UB)
Lower Lingual Incisor (LL)
Gingival Crevicular Fluid (GCF)
Single site (n=12/34; 35.3%)

Multiple sites (n=22/34; 64.7%)
Key
CT value

ND

20

25

Single site (n=12)

Multiple sites (n=59)

Total (n=71)

GCF, n=1/12 or 8.3%
LL, n=0
UB, n=3/12 or 25%
DT, n=5/12 or 7.0%
Saliva, n=3/71 or 25%

GCF, n=6/59 or 10.2%
LL, n=18/59 or 30.5%
UB, n=16/59 or 27.1%
DT, n=7/59 or 11.9%
Salva, n=12/59 or 20.3%

GCF, n=7/71 or 9.9%
LL, n=18/71 or 25.4%
UB, n=19/71 or 26.8%
DT, n=12/71 or 16.9%
Saliva, n=15/71 or 21.1%

30

35

B

Figure 2.
2. Heat
Figure
Heat map
map of
of study
study sample
sample molecular
molecularscreening
screeningfor
forS.S.wiggsiae.
wiggsiae.(A)
(A)Heat
Heatmap
mapofofthe
theqPCR
qPCRscreening
screeningrevealed
revealeda
total
of
n
=
34/60
or
56.7%
of
patient
samples
harboring
SW.
(B)
A
total
of
n
=
71/170
specific
oral
sites
harbored
this
a total of n = 34/60 or 56.7% of patient samples harboring SW. (B) A total of n = 71/170 specific oral sites harbored this
organism, with the majority of the SW-positive participant samples harboring SW at more than one oral site, n = 22/34 or
organism, with the majority of the SW-positive participant samples harboring SW at more than one oral site, n = 22/34 or
64.7%. Note: Key indicates relative DNA abundance through CT values: 20 = greater abundance; 35 = less abundant.
64.7%. Note: Key indicates relative DNA abundance through CT values: 20 = greater abundance; 35 = less abundant.

To
determine whether
whether there
there are
are any
any significant
significant associations
associations between
between SW-positive
SW-positive
To determine
site-specific
screening
(dependent)
outcomes
and
any
potential
predictor
variables
site-specific screening (dependent) outcomes and any potential predictor variables (age,
(age,
sex,
dentition, brackets),
assessed (Table
(Table 3).
3). These
These data
data
sex, BMI,
BMI, dentition,
brackets), Pearson’s
Pearson’s correlation
correlation was
was assessed
demonstrated
that
the
majority
of
variables
had
negligible
or
very
weak
associations
demonstrated that the majority of variables had negligible or very weak associations
between
analyzed and
and SW-positive
SW-positive outcomes
outcomes(between
(between0.0
0.0and
and0.19
0.19or
or −
−0.19).
between the
the variables
variables analyzed
0.19).
However, three weak associations were found between specific SW outcomes and specific
variables, which included a correlation between type of dentition (permanent) and SWpositive results with the GCF (R = 0.2444) and both age (R = 0.228) and presence of
orthodontic brackets (R = 0.2118) with SW-positive results in saliva.
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Table 3. Correlation of variables to SW-positive site-specific screening results.
Age

Sex

BMI

Dentition

Brackets

Gingival Crevice

R = −0.1945

R = 0.0611

R = 0.0950

R = 0.2444

R = −0.1437

Upper Buccal Molar

R = −0.0810

R = −0.0024

R = −0.0598

R = −0.0010

R = −0.0848

Lower Lingual Incisor

R = −0.0246

R = −0.1057

R = −0.0278

R = −0.1046

R = −0.0509

Dorsal Tongue

R = −0.1604

R = 0.1211

R = 0.0833

R = 0.1550

R = −0.0667

Saliva

R = 0.2228

R = 0.0399

R = −0.1701

R = −0.1139

R = 0.2118

Key:
Strength of Correlation (R)
Negligible/Very Weak
Weak
Moderate
Strong
Very Strong

Correlation Coefficient Range
0.0–0.19 or −0.19–0.0
0.20–0.39 or −0.39–−0.20
0.40–0.59 or −0.40–−0.59
0.60–0.79 or −0.79–−0.60
0.80–1.0 or −1.0–−0.80

4. Discussion
The objective of this current study was to facilitate a molecular screening of samples
with site-specific oral locations for SW. The results of this study clearly demonstrate that
molecular screening and identification of this novel cariogenic pathogen are feasible and
effective at determining site-specific locations that may harbor detectable levels, similar
to other molecular methods for oral screening and pathogen identification [29–31]. In
addition, this study may be among the first to describe the presence of this organism in
non-traditional oral sites and locations, such as the biofilm on the dorsum of the tongue
and GCF, which have not been oral sites or locations associated with the most prevalent
cariogenic- and supragingival biofilm-associated organisms, such as Lactobacillus spp. and
S. mutans [32–34].
Moreover, this study is among the first to provide an analysis and documentation of
the prevalence of single-site versus multi-site SW-positive samples from an oral biorepository, similar to other initiatives that attempted to map microbial distribution and body
sites for other types of medically important organisms, such as Staphylococcus aureus and
Clostridium difficile [35]. Although more than half of the sites harboring this organism were
traditional supragingival biofilm sites, such as the tooth biofilm of the upper buccal molar
and lower lingual incisor, less obvious sites were revealed such as the biofilm from the
dorsum of the tongue, which has been demonstrated in other studies to be an important
intermediate site for the movement and redistribution of oral microbes [36,37]. In fact,
this site has been recently recognized as an increasingly important site that contributes to
overall microbial burden and oral ecology through various mechanisms, including salivary
redistribution [38–41].
In addition to these novel insights, this study also provides the first evidence of
SW presence from the gingival crevice, an area more traditionally associated with periodontal pathogens and anaerobic Gram-negative microbes [42,43]. Although the majority
of GCF-associated SW-positive samples were found among patients with multi-site SWpositive results, at least one single-site positive sample was found to harbor SW only in
the GCF—which may suggest that more detailed and specific studies are needed to better
understand the potential microbial interactions in the subgingival biofilm and the gingival
crevice [44–46]. Indeed, there may be undiscovered mechanisms of polymicrobial synergy
or other interactions involving SW that more detailed studies in the future may be able to
elucidate, thus furthering our knowledge of oral health and disease [47,48].
Despite the significance of these findings, there are some limitations associated with
this study which should also be considered when evaluating this evidence. For example, at
least one significant difference was found between the ethnic and racial composition of the
study sample and the overall clinic demographics, which may suggest additional methods
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and protocols may be needed in future studies to reduce the potential for sampling and
enrollment bias [49,50]. In addition, there are limitations associated with the inferences
that can be made from this study due to the limitations of this pilot study sample size, a
common feature among many clinical and epidemiologic studies that attempt to produce
relevant clinical data without significant external funding sources [51,52].
5. Conclusions
This study may be among the first to provide oral site-specific analysis to reveal the
prevalence and location of Scardovia among clinical patient samples. Moreover, these data
also provide some of the first evidence to suggest this organism may be present not only
in traditional supragingival tooth-associated biofilm sites, but also in non-traditional oral
sites including the dorsum of the tongue and the gingival crevice. Based upon these results,
these data may represent a significant advance in our understanding of the potential sites
and locations that harbor this organism and may help contribute to our understanding of
the prevalence, distribution and potential for the development of oral disease among clinic
patients.
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